Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: a retrospective comparative study

BACKGROUND: Gemcitabine plus platinum as the first-line chemotherapy for cholangiocarcinoma (CCA) has limited efficacy. The aim of this study was to evaluate the effectiveness of modified FOLFIRINOX (mFOLFIRINOX) compared to that of gemcitabine plus oxaliplatin (Gemox) for patients with locally adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Lu, Li, Xuechuan, Wu, Xiangsong, Cui, Jiujie, Cui, Xuya, Song, Xiaoling, Ren, Tai, Han, Xusheng, Zhu, Yidi, Li, Huaifeng, Wu, Wenguang, Wang, Xu’an, Gong, Wei, Wang, Liwei, Li, Maolan, Lau, Wan Yee, Liu, Yingbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283916/
https://www.ncbi.nlm.nih.gov/pubmed/34266407
http://dx.doi.org/10.1186/s12885-021-08549-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283916/
https://www.ncbi.nlm.nih.gov/pubmed/34266407
http://dx.doi.org/10.1186/s12885-021-08549-2

Ejemplares similares